Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

375 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Repopulation of cancer cells during therapy: an important cause of treatment failure.
Kim JJ, Tannock IF. Kim JJ, et al. Among authors: tannock if. Nat Rev Cancer. 2005 Jul;5(7):516-25. doi: 10.1038/nrc1650. Nat Rev Cancer. 2005. PMID: 15965493 Review.
Effects of agents which inhibit the regulation of intracellular pH on murine solid tumours.
Newell K, Wood P, Stratford I, Tannock I. Newell K, et al. Br J Cancer. 1992 Aug;66(2):311-7. doi: 10.1038/bjc.1992.262. Br J Cancer. 1992. PMID: 1503904 Free PMC article.
Chemotherapy for recurrent or metastatic carcinoma of the nasopharynx. A review of the Princess Margaret Hospital experience.
Choo R, Tannock I. Choo R, et al. Cancer. 1991 Nov 15;68(10):2120-4. doi: 10.1002/1097-0142(19911115)68:10<2120::aid-cncr2820681005>;2-7. Cancer. 1991. PMID: 1913449
Evolution of clinical trial design in early drug development: systematic review of expansion cohort use in single-agent phase I cancer trials.
Manji A, Brana I, Amir E, Tomlinson G, Tannock IF, Bedard PL, Oza A, Siu LL, Razak AR. Manji A, et al. Among authors: tannock if. J Clin Oncol. 2013 Nov 20;31(33):4260-7. doi: 10.1200/JCO.2012.47.4957. Epub 2013 Oct 14. J Clin Oncol. 2013. PMID: 24127441 Review.
Scheduling of radiation and chemotherapy for limited-stage small-cell lung cancer: repopulation as a cause of treatment failure?
Brade AM, Tannock IF. Brade AM, et al. Among authors: tannock if. J Clin Oncol. 2006 Mar 1;24(7):1020-2. doi: 10.1200/JCO.2005.04.9676. J Clin Oncol. 2006. PMID: 16505418 No abstract available.
Risk of incremental toxicities and associated costs of new anticancer drugs: a meta-analysis.
Niraula S, Amir E, Vera-Badillo F, Seruga B, Ocana A, Tannock IF. Niraula S, et al. Among authors: tannock if. J Clin Oncol. 2014 Nov 10;32(32):3634-42. doi: 10.1200/JCO.2014.55.8437. Epub 2014 Sep 29. J Clin Oncol. 2014. PMID: 25267757
A fatal case of Pneumocystis jirovecii pneumonia in a breast cancer patient receiving weekly paclitaxel and trastuzumab.
Kim S, Bordeleau L, Tannock IF, Rotstein C. Kim S, et al. Among authors: tannock if. J Oncol Pharm Pract. 2012 Jun;18(2):293-5. doi: 10.1177/1078155211412991. Epub 2011 Sep 12. J Oncol Pharm Pract. 2012. PMID: 21911478
Delivery of meaningful cancer care: a retrospective cohort study assessing cost and benefit with the ASCO and ESMO frameworks.
Del Paggio JC, Sullivan R, Schrag D, Hopman WM, Azariah B, Pramesh CS, Tannock IF, Booth CM. Del Paggio JC, et al. Among authors: tannock if. Lancet Oncol. 2017 Jul;18(7):887-894. doi: 10.1016/S1470-2045(17)30415-1. Epub 2017 Jun 2. Lancet Oncol. 2017. PMID: 28583794
Under-reporting of harm in clinical trials.
Seruga B, Templeton AJ, Badillo FE, Ocana A, Amir E, Tannock IF. Seruga B, et al. Among authors: tannock if. Lancet Oncol. 2016 May;17(5):e209-19. doi: 10.1016/S1470-2045(16)00152-2. Epub 2016 Apr 27. Lancet Oncol. 2016. PMID: 27301048 Review.
Outcomes and endpoints in cancer trials: bridging the divide.
Wilson MK, Collyar D, Chingos DT, Friedlander M, Ho TW, Karakasis K, Kaye S, Parmar MK, Sydes MR, Tannock IF, Oza AM. Wilson MK, et al. Among authors: tannock if. Lancet Oncol. 2015 Jan;16(1):e43-52. doi: 10.1016/S1470-2045(14)70380-8. Epub 2014 Dec 29. Lancet Oncol. 2015. PMID: 25638556 Review.
375 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page